Estimation Of Tenascin-X, Sphingosine and HOMA-IR Cut-Off Values For Obese Adults

Nagham Qasim Kadhim

doi:10.61132/obat.v2i5.644

Authors

Nagham Qasim Kadhim Universitas Tikrit

DOI:

https://doi.org/10.61132/obat.v2i5.644

Keywords:

Tenascin-X, Sphingosine , HOMA-IR, Cut-off

Abstract

Tenascins are glycoproteins groups found in the extra-cellular matrix . The sphingolipidome in blood distinguished as a hundreds types of fats with many different essential chemical and physical properties. Insulin resistance is impaired biologic response of many target tissues to stimulation of insulin, and all tissues that have insulin receptors exposed insulin resistant. Materials and methods: Sixty sampling were participated, their ages ranged from (30-38) years. Biochemical measurements: insulin by AFIAS-10 , TN-X and sphingosine measured by kits by Sun Long Biotech – China. Results:- the level of Tenascin-X, sphingosine and HOMA-IR in the obese group increase significantly (P<0.01) when compared to non-obese group. Cut-off for Tenascin-X was 10.382pg./ml, for sphingosine was 10.93 ng./ml, and for HOMA-IR was 1.43 ng./ml. Conclusions: tenascin-X sphingosine and HOMA-IR were related with obesity. Tenascin-X, Sphingosine and HOMA-IR were related to obesity

Downloads

Download data is not yet available.

References

Baek, G. H., Yoo, K. M., Kim, S.-Y., Lee, D. H., Chung, H., Jung, S.-C., Park, S.-K., & Kim, J.-S. (2023). Collagen peptide exerts an anti-obesity effect by influencing the Firmicutes/Bacteroidetes ratio in the gut. Nutrients, 15, 2610.

Barbacini, P., Torretta, E., Arosio, B., Ferri, E., Capitanio, D., Moriggi, M., & Gelfi, C. (2022). Novel insight into the serum sphingolipid fingerprint characterizing longevity. International Journal of Molecular Sciences, 23(5), 2428.

Bartke, N., & Hannun, Y. A. (2009). Bioactive sphingolipids: Metabolism and function. Journal of Lipid Research, 50(Suppl), S91–S96.

Chiquet-Ehrismann, R., & Chiquet, M. (2003). Tenascins: Regulation and putative functions during pathological stress. Journal of Pathology, 200(4), 488–499.

Choi, R. H., Tatum, S. M., Symons, J. D., Summers, S. A., & Holland, W. L. (2021). Ceramides and other sphingolipids as drivers of cardiovascular disease. Nature Reviews Cardiology.

Cuvillier, O. (2002). Sphingosine in apoptosis signaling. Biochimica et Biophysica Acta, 1585(2–3), 153–162.

De la Cruz-Concepción, B., Flores-Cortez, Y. A., Barragán-Bonilla, M. I., Mendoza-Bello, J. M., & Espinoza-Rojo, M. (2023). Insulin: A connection between pancreatic β cells and the hypothalamus. World Journal of Diabetes, 14(2), 76–91. https://doi.org/10.4239/wjd.v14.i2.76

Eizirik, D. L., Pasquali, L., & Cnop, M. (2020). Pancreatic β-cells in type 1 and type 2 diabetes mellitus: Different pathways to failure. Nature Reviews Endocrinology, 16, 349–362.

Freeman, A. M., Acevedo, L. A., & Pennings, N. (2023). Insulin resistance. In StatPearls [Internet]. StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29939616

Green, C., Ghali, N., Akilapa, R., Angwin, C., Baker, D., Bartlett, M., & et al. (2020). Classical-like Ehlers–Danlos syndrome: A clinical description of 20 newly identified individuals with evidence of tissue fragility. Genetics in Medicine, 22(10), 1576–1582.

Juchnicka, I., Kuz´micki, M., & Szamatowicz, J. (2021). Ceramides and sphingosine-1-phosphate in obesity. Frontiers in Endocrinology, 12, 635995.

Khanna, D., Khanna, S., Khanna, P., Kahar, P., & Patel, B. (2022). Obesity: A chronic low-grade inflammation and its markers. Cureus, 14, e22711. https://doi.org/10.7759/cureus.22711

Lemaitre, R. N., Yu, C., Hoofnagle, A., Hari, N., Jensen, P. N., Fretts, A. M., Umans, J. G., Howard, B. V., Sitlani, C. M., Siscovick, D. S., King, I. B., Sotoodehnia, N., & McKnight, B. (2018). Circul

Li, M., Chi, X., Wang, Y., & et al. (2022). Trends in insulin resistance: Insights into mechanisms and therapeutic strategy. Signal Transduction and Targeted Therapy, 7, 216.

Matsumoto, K.-i., & Aoki, H. (2020). The roles of tenascins in cardiovascular, inflammatory, and heritable connective tissue diseases. Frontiers in Immunology, 11, 609752.

McGurk, K. A., Keavney, B. D., & Nicolaou, A. (2021). Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies. Atherosclerosis, 327, 18–30.

Neeland, I. J., Singh, S., McGuire, D. K., Vega, G. L., Roddy, T., Reilly, D. F., Castro-Perez, J., Kozlitina, J., & Scherer, P. E. (2018). Relation of plasma ceramides to visceral adiposity, insulin resistance, and the development of type 2 diabetes mellitus: The Dallas Heart Study. Diabetologia, 61(12), 2570–2579.

Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993). Programmed cell death induced by ceramide. Science, 259(5102), 1769–1771.

Park, S. Y., Gautier, J. F., & Chon, S. (2021). Assessment of insulin secretion and insulin resistance in humans. Diabetes & Metabolism Journal, 45, 641–654.

Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023). Obesity and cancer: A current overview of epidemiology, pathogenesis, outcomes, and management. Cancers, 15, 485.

Peters, L., Kuebler, W. M., & Simmons, S. (2022). Sphingolipids in atherosclerosis: Chimeras in structure and function. International Journal of Molecular Sciences, 23, 11948.

Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M. G. (2021). Role of insulin in health and disease: An update. International Journal of Molecular Sciences, 22.

Speek, M., Barry, F., & Miller, W. L. (1996). Alternate promoters and alternate splicing of human tenascin-X, a gene with 5′ and 3′ ends buried in other genes. Human Molecular Genetics, 5(11), 1749–1758.

Tahapary, D. L., Pratisthita, L. B., Fitri, N. A., Marcella, C., Wafa, S., Kurniawan, F., Rizka, A., Tarigan, T. J. E., Harbuwono, D. S., Purnamasari, D., Soewondo, P. (2022). Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and triglyceride/glucose index. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 16, 102581.

Thudichum, J. (1884). A treatise on the chemical constitution of the brain. Bailliere, Tindall, and Cox.

Valcourt, U., Alcaraz, L. B., Exposito, J. Y., Lethias, C., & Bartholin, L. (2015). Tenascin-X: Beyond the architectural function. Cell Adhesion & Migration, 9(1–2), 154–165.

Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. C., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine, 17(2), 179–188.

Volpe, M., & Gallo, G. (2023). Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Frontiers in Cardiovascular Medicine, 10, 1136340.

Zhang, Q., Lu, C., Lu, F., Liao, Y., Cai, J., & Gao, J. (2024). Challenges and opportunities in obesity: The role of adipocytes during tissue fibrosis. Frontiers in Endocrinology, 15, 1365156.